Genetics of rheumatoid arthritis: GWAS and beyond

Open Access Rheumatology: Research and Reviews

Volumn 3, Issue , 2011, Pages 31-46

  McAllister, Kate ^a   Eyre, Stephen ^a   Orozco, Gisela ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Bioinformatics; Fine mapping; GWAS; Immunochip; Rheumatoid arthritis

Indexed keywords

HLA DRB1 ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; STAT4 PROTEIN;

DISEASE ASSOCIATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENE LOCUS; GENE TECHNOLOGY; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HERITABILITY; HUMAN; HUMAN GENOME; MOLECULAR TYPING; PHENOTYPE; QUANTITATIVE TRAIT; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84855283714     PISSN: None     EISSN: 1179156X     Source Type: Journal    
DOI: 10.2147/OARRR.S14725     Document Type: Review

References (154)

1. Worthington J. Investigating the genetic basis of susceptibility to rheumatoid arthritis. J Autoimmun. 2005; 25 Suppl:16-20.
2. Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007; 21(5): 907-927.
3. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010; 376(9746):1094-1108.
4. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev. 2005; 4(3):130-136.
5. Reginster JY. The prevalence and burden of arthritis. Rheumatology (Oxford). 2002; 41(Suppl 1):3-6.
6. Deighton CM, Walker DJ. The familial nature of rheumatoid arthritis. Ann Rheum Dis. 1991; 50(1):62-65.
7. Wordsworth P, Bell J. Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis. 1991; 50(6):343-346.
8. Jarvinen P, Aho K. Twin studies in rheumatic diseases. Semin Arthritis Rheum. 1994; 24(1):19-28.
9. Silman AJ, MacGregor AJ, Thomson W, et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol. 1993; 32(10):903-907.
10. MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000; 43(1):30-37.
11. Van der Linden M P, Feitsma AL, le Cessie S, et al. Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum. 2009; 60(8): 2242-2247.
12. Stolt P, Bengtsson C, Nordmark B, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis. 2003; 62(9):835-841.
13. Tobon GJ, Youinou P, Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev. 2010; 9(5):A288-A292.
14. Symmons DP. Environmental factors and the outcome of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2003; 17(5):717-727.
15. Oliver JE, Silman AJ. Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol. 2006; 35(3):169-174.
16. Stahl EA, Raychaudhuri S, Remmers EF, et al. Genome-wide association study meta-analysis identifes seven new rheumatoid arthritis risk loci. Nat Genet. 2010; 42(6):508-514.
17. Morgan AW, Robinson JI, Conaghan PG, et al. Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/ TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort. Arthritis Res Ther. 2010; 12(2):R57.
18. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med. 1978; 298(16):869-871.
19. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987; 30(11):1205-1213.
20. Fernando MM, Stevens CR, Walsh EC, et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet. 2008; 4(4):e1000024.
21. Lee HS, Lee AT, Criswell LA, et al. Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus. Mol Med. 2008; 14(5-6):293-300.
22. Raychaudhuri S. Recent advances in the genetics of rheumatoid arthritis. Curr Opin Rheumatol. 2010; 22(2):109-118.
23. Ding B, Padyukov L, Lundstrom E, et al. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum. 2009; 60(1):30-38.
24. Michou L, Croiseau P, Petit-Teixeira E, et al. Validation of the reshaped shared epitope HLA-DRB1 classifcation in rheumatoid arthritis. Arthritis Res Ther. 2006; 8(3):R79.
25. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lym-phoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004; 36(4):337-338.
26. Begovich AB, Carlton VE, Honigberg LA, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phos-phatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004; 75(2):330-337.
27. Farago B, Talian GC, Komlosi K, et al. Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects. Rheumatol Int. 2009; 29(7):793-796.
28. Kokkonen H, Johansson M, Innala L, Jidell E, Rantapaa-Dahlqvist S. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther. 2007; 9(3):R56.
29. Pierer M, Kaltenhauser S, Arnold S, et al. Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients. Arthritis Res Ther. 2006; 8(3):R75.
30. Plenge RM, Padyukov L, Remmers E F, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in.4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet. 2005; 77(6): 1044-1060.
31. Simkins HM, Merriman ME, Highton J, et al. Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort. Arthritis Rheum. 2005; 52(7):2222-2225.
32. Viken MK, Olsson M, Flam ST, et al. The PTPN22 promoter polymorphism -1123G. C association cannot be distinguished from the 1858C. T association in a Norwegian rheumatoid arthritis material. Tissue Antigens. 2007; 70(3):190-197.
33. Wesoly J, Hu X, Thabet MM, et al. The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch population. Rheumatology (Oxford). 2007; 46(4):617-621.
34. Zhernakova A, Eerligh P, Wijmenga C, Barrera P, Roep BO, Koeleman BP. Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population. Genes Immun. 2005; 6(6):459-461.
35. Chelala C, Duchatelet S, Joffret ML, et al. PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits. Diabetes. 2007; 56(2):522-526.
36. Chung SA, Criswell LA. PTPN22: its role in SLE and autoimmunity. Autoimmunity. 2007; 40(8):582-590.
37. Criswell LA, Pfeiffer KA, Lum R F, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet. 2005; 76(4):561-571.
38. Hinks A, Worthington J, Thomson W. The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis. Rheumatology (Oxford). 2006; 45(4):365-368.
39. Orozco G, Sanchez E, Gonzalez-Gay MA, et al. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 2005; 52(1):219-224.
40. Kochi Y, Suzuki A, Yamada R, Yamamoto K. Genetics of rheumatoid arthritis: underlying evidence of ethnic differences. J Autoimmun. 2009; 32(3-4):158-162.
41. Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet. 2005; 37(12):1317-1319.
42. Korman BD, Kastner DL, Gregersen PK, Remmers EF. STAT4: genetics, mechanisms, and implications for autoimmunity. Curr Allergy Asthma Rep. 2008; 8(5):398-403.
43. Lee HS, Remmers EF, Le JM, Kastner DL, Bae SC, Gregersen PK. Association of STAT4 with rheumatoid arthritis in the Korean population. Mol Med. 2007; 13(9-10):455-460.
44. Kobayashi S, Ikari K, Kaneko H, et al. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum. 2008; 58(7):1940-1946.
45. Martinez A, Varade J, Marquez A, et al. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. Arthritis Rheum. 2008; 58(9):2598-2602.
46. Zervou MI, Mamoulakis D, Panierakis C, Boumpas DT, Goulielmos GN. STAT4: a risk factor for type 1 diabetes? Hum Immunol. 2008; 69(10): 647-650.
47. Wurster AL, Tanaka T, Grusby MJ. The biology of Stat4 and Stat6. Oncogene. 2000; 19(21):2577-2584.
48. Kannan K, Ortmann RA, Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology. 2005; 12(3):167-181.
49. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996; 273(5281):1516-1517.
50. Zhu M, Zhao S. Candidate gene identifcation approach: progress and challenges. Int J Biol Sci. 2007; 3(7):420-427.
51. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001; 409(6822):860-921.
52. International HapMap Consortium. A haplotype map of the human genome. Nature. 2005; 437(7063):1299-1320.
53. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet. 2001; 17(9):502-510.
54. Pritchard JK, Cox NJ. The allelic architecture of human disease genes: common disease-common variant...or not? Hum Mol Genet. 2002; 11(20):2417-2423.
55. Hindorff LA, Junkins HA, Hall PN, Mehta J P, Manolio TA. A catalog of published genome-wide association studies. December 12, 2010. Available at: http://www.genome.gov/gwastudies/. Accessed April 21, 2011.
56. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447(7145):661-678.
57. Thomson W, Barton A, Ke X, et al. Rheumatoid arthritis association at 6q23. Nat Genet. 2007; 39(12):1431-1433.
58. Plenge RM, Cotsapas C, Davies L, et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet. 2007; 39(12):1477-1482.
59. Orozco G, Hinks A, Eyre S, et al. Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Hum Mol Genet. 2009; 18(14):2693-2699.
60. Coornaert B, Carpentier I, Beyaert R. A20: central gatekeeper in infam-mation and immunity. J Biol Chem. 2009; 284(13):8217-8221.
61. Vereecke L, Beyaert R, van LG. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 2009; 30(8):383-391.
62. Brown KD, Claudio E, Siebenlist U. The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther. 2008; 10(4):212.
63. Lee EG, Boone DL, Chai S, et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-defcient mice. Science. 2000; 289(5488):2350-2354.
64. Elsby LM, Orozco G, Denton J, Worthington J, Ray DW, Donn RP. Functional evaluation of TNFAIP3 (A20) in rheumatoid arthritis. Clin Exp Rheumatol. 2010; 28(5):708-714.
65. Kochi Y, Okada Y, Suzuki A, et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet. 2010; 42(6):515-519.
66. Julia A, Ballina J, Canete JD, et al. Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility. Arthritis Rheum. 2008; 58(8): 2275-2286.
67. Gregersen PK, Amos CI, Lee AT, et al. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defned risk locus for rheumatoid arthritis. Nat Genet. 2009; 41(7):820-823.
68. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med. 2007; 357(12):1199-1209.
69. Eyre S, Hinks A, Flynn E, et al. Confrmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population. Ann Rheum Dis. 2010; 69(8):1572-1573.
70. Spencer CC, Su Z, Donnelly P, Marchini J. Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genet. 2009; 5(5):e1000477.
71. Raychaudhuri S, Remmers E F, Lee AT, et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet. 2008; 40(10):1216-1223.
72. Orozco G, Eyre S, Hinks A, et al. Association of CD40 with rheumatoid arthritis confrmed in a large UK case-control study. Ann Rheum Dis. 2010; 69(5):813-816.
73. Tomer Y, Concepcion E, Greenberg DA. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid. 2002; 12(12):1129-1135.
74. Kim TY, Park YJ, Hwang JK, et al. A C/T polymorphism in the 5'-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid. 2003; 13(10):919-925.
75. Mukai T, Hiromatsu Y, Fukutani T, et al. A C/T polymorphism in the 5' untranslated region of the CD40 gene is associated with later onset of Graves' disease in Japanese. Endocr J. 2005; 52(4): 471-477.
76. Australia and New Zealand Multiple Sclerosis Genetics Consortium. Genome-wide association study identifes new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet. 2009; 41(7): 824-828.
77. Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007; 39(7):857-864.
78. Van Heel DA, Franke L, Hunt KA, et al. A genome-wide association study for celiac disease identifes risk variants in the region harboring IL2 and IL21. Nat Genet. 2007; 39(7):827-829.
79. Zhernakova A, Alizadeh BZ, Bevova M, et al. Novel association in chromosome 4q27 region with rheumatoid arthritis and confrmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet. 2007; 81(6):1284-1288.
80. Festen EA, Goyette P, Scott R, et al. Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis. Gut. 2009; 58(6):799-804.
81. Albers HM, Kurreeman FA, Stoeken-Rijsbergen G, et al. Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritis. Arthritis Rheum. 2009; 60(3):901-904.
82. Liu Y, Helms C, Liao W, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifes new disease loci. PLoS Genet. 2008; 4(3):e1000041.
83. Marquez A, Orozco G, Martinez A, et al. Novel association of the interleukin 2-interleukin 21 region with infammatory bowel disease. Am J Gastroenterol. 2009; 104(8):1968-1975.
84. Malek TR. The biology of interleukin-2. Annu Rev Immunol. 2008; 26:453-479.
85. Young DA, Hegen M, Ma HL, et al. Blockade of the interleukin-21/ interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum. 2007; 56(4):1152-1163.
86. Raychaudhuri S, Plenge RM, Rossin EJ, et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 2009; 5(6):e1000534.
87. Raychaudhuri S, Thomson B P, Remmers EF, et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet. 2009; 41(12):1313-1318.
88. Orozco G, Barrett JC, Zeggini E. Synthetic associations in the context of genome-wide association scan signals. Hum Mol Genet. 2010; 19(R2):R137-R144.
89. Huffmeier U, Bergboer JG, Becker T, et al. Replication of LCE3C-LCE3B CNV as a risk factor for psoriasis and analysis of interaction with other genetic risk factors. J Invest Dermatol. 2010; 130(4): 979-984.
90. Mamtani M, Rovin B, Brey R, et al. CCL3L1 gene-containing seg-mental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis. 2008; 67(8): 1076-1083.
91. McKinney C, Merriman ME, Chapman PT, et al. Evidence for an infuence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis. 2008; 67(3):409-413.
92. McCarroll SA, Huett A, Kuballa P, et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet. 2008; 40(9):1107-1112.
93. Grayson BL, Smith ME, Thomas J W, et al. Genome-wide analysis of copy number variation in type 1 diabetes. PLoS One. 2010; 5(11): e15393.
94. Craddock N, Hurles ME, Cardin N, et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature. 2010; 464(7289):713-720.
95. Durbin RM, Abecasis GR, Altshuler DL, et al. A map of human genome variation from population-scale sequencing. Nature. 2010; 467(7319):1061-1073.
96. Mahdi H, Fisher BA, Kallberg H, et al. Specifc interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet. 2009; 41(12): 1319-1324.
97. Thomas D. Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies. Annu Rev Public Health. 2010; 31:21-36.
98. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9):2569-2581.
99. Weyand CM, Klimiuk PA, Goronzy JJ. Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes. Springer Semin Immunopathol. 1998; 20(1-2):5-22.
100. Berglin E, Padyukov L, Sundin U, et al. A combination of autoanti-bodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther. 2004; 6(4):R303-R308.
101. Van der WD, Huizinga T.W. Every shared epitope allele for itself? Nat Rev Rheumatol. 2009; 5(9):477-478.
102. Padyukov L, Seielstad M, Ong RT, et al. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis. 2010; 70(2):259-265.
103. van der WD, Houwing-Duistermaat JJ, Toes RE, et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum. 2009; 60(4):916-923.
104. Plomin R, Haworth CM, Davis OS. Common disorders are quantitative traits. Nat Rev Genet. 2009; 10(12):872-828.
105. Kochi Y, Suzuki A, Yamada R, Yamamoto K. Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis. Nat Rev Rheu-matol. 2010; 6(5):290-295.
106. Suzuki A, Yamada R, Chang X, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylargininedeiminase 4, are associated with rheumatoid arthritis. Nat Genet. 2003; 34(4): 395-402.
107. Ikari K, Kuwahara M, Nakamura T, et al. Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum. 2005; 52(10):3054-3057.
108. Kang C P, Lee HS, Ju H, Cho H, Kang C, Bae SC. A functional hap-lotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum. 2006; 54(1): 90-96.
109. Burr ML, Naseem H, Hinks A, et al. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann Rheum Dis. 2010; 69(4):666-670.
110. Barton A, Bowes J, Eyre S, et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum. 2004; 50(4):1117-1121.
111. Iwamoto T, Ikari K, Nakamura T, et al. Association between PADI4 and rheumatoid arthritis: a meta-analysis. Rheumatology (Oxford) 2006; 45(7):804-807.
112. Alamanos Y, Voulgari P V, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006; 36(3):182-188.
113. Brand O, Gough S, Heward J. HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity? Expert Rev Mol Med. 2005; 7(23):1-15.
114. Dieude P, Guedj M, Wipff J, et al. The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis. Arthritis Rheum. 2008; 58(7):2183-2188.
115. Vang T, Miletic AV, Bottini N, Mustelin T. Protein tyrosine phos-phatase PTPN22 in human autoimmunity. Autoimmunity. 2007; 40(6):453-461.
116. Daha NA, Kurreeman FA, Marques RB, et al. Confrmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis. Arthritis Rheum. 2009; 60(5):1255-1260.
117. Glas J, Seiderer J, Nagy M, et al. Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset. PLoS One. 2010; 5(4):e10373.
118. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Association between the rs7574865 polymorphism of STAT4 and rheumatoid arthritis: a meta-analysis. Rheumatol Int. 2010; 30(5):661-666.
119. Moon CM, Cheon JH, Kim SW, et al. Association of signal transducer and activator of transcription 4 genetic variants with extra-intestinal manifestations in inflammatory bowel disease. Life Sci. 2010; 86(17-18):661-667.
120. Prahalad S, Hansen S, Whiting A, et al. Variants in TNFAIP3, STAT4, and C12 or f30 loci associated with multiple autoimmune diseases are also associated with juvenile idiopathic arthritis. Arthritis Rheum. 2009; 60(7):2124-2130.
121. Remmers EF, Plenge RM, Lee AT, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007; 357(10):977-986.
122. Zhernakova A, Eerligh P, Barrera P, et al. CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Hum Genet. 2005; 118(1):58-66.
123. Zhao SX, Pan CM, Cao HM, et al. Association of the CTLA4 gene with Graves' disease in the Chinese Han population. PLoS One. 2010; 5(3):e9821.
124. Lester S, Downie-Doyle S, Rischmueller M. CTLA4 polymorphism and primary Sjogren's syndrome. Arthritis Res Ther. 2007; 9(3):401.
125. Einarsdottir E, Soderstrom I, Lofgren-Burstrom A, et al. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. Eur J Hum Genet. 2003; 11(1):81-84.
126. Chistiakov DA, Turakulov RI. CTLA-4 and its role in autoimmune thyroid disease. J Mol Endocrinol. 2003; 31(1):21-36.
127. Ayadi H, Hadj KH, Rebai A, Farid NR. The genetics of autoimmune thyroid disease. Trends Endocrinol Metab. 2004; 15(5):234-239.
128. Ban Y, Tomer Y. Genetic susceptibility in thyroid autoimmunity. Pediatr Endocrinol Rev. 2005; 3(1):20-32.
129. Deng Y, Tsao BP. Genetic susceptibility to systemic lupus erythema-tosus in the genomic era. Nat Rev Rheumatol. 2010; 6(12):683-692.
130. Holmes S, Friese MA, Siebold C, Jones E Y, Bell J, Fugger L. Multiple sclerosis: MHC associations and therapeutic implications. Expert Rev Mol Med. 2005; 7(3):1-17.
131. Iwasa K, Kato-Motozaki Y, Furukawa Y, et al. Up-regulation of MHC class I and class II in the skeletal muscles of myasthenia gravis. J Neuroimmunol. 2010; 225(1-2):171-174.
132. Loiseau P, Lepage V, Djelal F, et al. HLA class I and class II are both associated with the genetic predisposition to primary Sjogren syndrome. Hum Immunol. 2001; 62(7):725-731.
133. Pender M P, Greer JM. Immunology of multiple sclerosis. Curr Allergy Asthma Rep. 2007; 7(4):285-292.
134. Rioux JD, Goyette P, Vyse TJ, et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci U S A. 2009; 106(44):18680-18685.
135. Thomas G P, Brown MA. Genetics and genomics of ankylosing spondylitis. Immunol Rev. 2010; 233(1):162-180.
136. Waterman M, Xu W, Stempak JM, et al. Distinct and overlapping genetic loci in crohn's disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis. 2010; Dec 10. [Epub ahead of print].
137. Dieude P, Guedj M, Wipff J, et al. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis. 2010; 69(11):1958-1964.
138. Eyre S, Hinks A, Bowes J, et al. Overlapping genetic susceptibility variants between three autoimmune disorders: rheumatoid arthritis, type 1 diabetes and coeliac disease. Arthritis Res Ther. 2010; 12(5):R175.
139. Fung EY, Smyth DJ, Howson JM, et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifes 6q23/TNFAIP3 as a susceptibility locus. Genes Immun. 2009; 10(2):188-191.
140. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared patho-genesis from the shared genetics of immune-related diseases. Nat Rev Genet. 2009; 10(1):43-55.
141. Nishimoto K, Kochi Y, Ikari K, et al. Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese. Ann Rheum Dis. 2010; 69(2): 368-373.
142. Kurreeman FA, Goulielmos GN, Alizadeh BZ, et al. The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases. Ann Rheum Dis. 2010; 69(4):696-699.
143. Hinks A, Eyre S, Ke X, et al. Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis. Ann Rheum Dis. 2010; 69(6):1049-1053.
144. Behrens EM, Finkel TH, Bradfield J P, et al. Association of the TRAF1-C5 locus on chromosome 9 with juvenile idiopathic arthritis. Arthritis Rheum. 2008; 58(7):2206-2207.
145. Maier LM, Lowe CE, Cooper J, et al. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet. 2009; 5(1): e1000322.
146. Brand OJ, Lowe CE, Heward JM, et al. Association of the interleukin-2 receptor alpha (IL-2R alpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf). 2007; 66(4):508-512.
147. Blanco-Kelly F, Matesanz F, Alcina A, et al. CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility. PLoS One. 2010; 5(7):e11520.
148. Wang K, Baldassano R, Zhang H, et al. Comparative genetic analysis of infammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet. 2010; 19(10): 2059-2067.
149. Park JH, Wacholder S, Gail MH, et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet. 2010; 42(7):570-575.
150. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther. 2011; 13(1):101.
151. Martin P, Barton A, Eyre S. ASSIMILATOR: a new tool to inform selection of associated genetic variants for functional studies. Bioin-formatics. 2011; 27(1):144-146.
152. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 2010; 6(4):e1000888.
153. Moffatt M F, Kabesch M, Liang L, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature. 2007; 448(7152):470-473.
154. Ge B, Pokholok DK, Kwan T, et al. Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat Genet. 2009; 41(11):1216-1222.